Literature DB >> 28331260

Early Enteral Nutrition Versus Parenteral Nutrition After Resection of Esophageal Cancer: a Retrospective Analysis.

Huan Ming Yu1, Cheng Wu Tang2, Wen Ming Feng2, Qiu Qiang Chen1, Yong Qiang Xu2, Ying Bao2.   

Abstract

This study aimed to compare the clinical outcomes and hospitalization cost between early enteral nutrition (EEN) and parenteral nutrition (PN) after resection of esophageal cancer. A total of 79 patients with esophageal cancer who underwent surgical treatment in our hospital from July 2010 to July 2013 were enrolled in this study. They were divided into EEN group (n = 39) and PN group (n = 40) based on the nutrition support modes. The clinical factors such as time to first fecal passage, postoperative albumin infusion, differences of serum albumin value, hospital stay, systematic inflammatory response syndrome (SIRS) duration, complications, initial hospitalization cost, and mortality were retrospectively compared. The EEN group had a significantly shorter hospital stay, lower initial hospitalization cost, earlier first fecal passage, and shorter duration of SIRS than PN group (P < 0.05). The dose of albumin infusion was significantly smaller in EEN group (P < 0.05) and the decreased value of serum albumin (Δalb) was more prominent in PN group compared with EEN group (P < 0.05). The percentage of patients having any postoperative complication was much higher in PN group than EEN group (P < 0.05), but there was no significant difference in in-hospital morbidity between two groups. Pneumonia was found significantly more frequent in PN group compared with EEN group (P < 0.05). Early EN started within 48 h after esophagectomy is safe, economic, and superior for reduction of postoperative complication, for promoting early recovery of intestinal movement, and for early recovery from systemic inflammation.

Entities:  

Keywords:  Complication; Enteral nutrition; Esophageal cancer; Parenteral nutrition

Year:  2015        PMID: 28331260      PMCID: PMC5346080          DOI: 10.1007/s12262-015-1420-7

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  27 in total

1.  Outcomes after esophagectomy: a ten-year prospective cohort.

Authors:  Stephen H Bailey; David A Bull; David H Harpole; Jeffrey J Rentz; Leigh A Neumayer; Theodore N Pappas; Jennifer Daley; William G Henderson; Barbara Krasnicka; Shukri F Khuri
Journal:  Ann Thorac Surg       Date:  2003-01       Impact factor: 4.330

2.  Early enteral feeding compared with parenteral nutrition after oesophageal or oesophagogastric resection and reconstruction.

Authors:  S Gabor; H Renner; V Matzi; B Ratzenhofer; J Lindenmann; O Sankin; H Pinter; A Maier; J Smolle; F M Smolle-Jüttner
Journal:  Br J Nutr       Date:  2005-04       Impact factor: 3.718

Review 3.  Artificial nutrition support in hospital: indications and complications.

Authors:  Trevor Smith; Marinos Elia
Journal:  Clin Med (Lond)       Date:  2006 Sep-Oct       Impact factor: 2.659

4.  Risk factors that influence early death due to cancer recurrence after extended radical esophagectomy with three-field lymph node dissection.

Authors:  Shin-Ichi Kosugi; Tatsuo Kanda; Kazuhito Yajima; Takashi Ishikawa; Katsuyoshi Hatakeyama
Journal:  Ann Surg Oncol       Date:  2011-04-16       Impact factor: 5.344

5.  Enteral feeding in esophageal surgery.

Authors:  C D Mercer; A Mungara
Journal:  Nutrition       Date:  1996-03       Impact factor: 4.008

6.  Intravenous hydration versus naso-jejunal enteral feeding after esophagectomy: a randomised study.

Authors:  Richard D Page; Aung Y Oo; Glen N Russell; Stephen H Pennefather
Journal:  Eur J Cardiothorac Surg       Date:  2002-11       Impact factor: 4.191

7.  Early enteral nutrition reduces the rate of life-threatening complications after thoracic esophagectomy in patients with esophageal cancer.

Authors:  T Fujita; H Daiko; M Nishimura
Journal:  Eur Surg Res       Date:  2012-03-01       Impact factor: 1.745

8.  Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial.

Authors:  Surya S A Y Biere; Mark I van Berge Henegouwen; Kirsten W Maas; Luigi Bonavina; Camiel Rosman; Josep Roig Garcia; Suzanne S Gisbertz; Jean H G Klinkenbijl; Markus W Hollmann; Elly S M de Lange; H Jaap Bonjer; Donald L van der Peet; Miguel A Cuesta
Journal:  Lancet       Date:  2012-05-01       Impact factor: 79.321

9.  A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy.

Authors:  M J Heslin; L Latkany; D Leung; A D Brooks; S N Hochwald; P W Pisters; M Shike; M F Brennan
Journal:  Ann Surg       Date:  1997-10       Impact factor: 12.969

10.  Early enteral nutrition, provided within 24 h of injury or intensive care unit admission, significantly reduces mortality in critically ill patients: a meta-analysis of randomised controlled trials.

Authors:  Gordon S Doig; Philippa T Heighes; Fiona Simpson; Elizabeth A Sweetman; Andrew R Davies
Journal:  Intensive Care Med       Date:  2009-09-24       Impact factor: 17.440

View more
  3 in total

1.  Risk factors for postoperative pneumonia after general and digestive surgery: a retrospective single-center study.

Authors:  Hayato Baba; Ryutaro Tokai; Katsuhisa Hirano; Toru Watanabe; Kazuto Shibuya; Isaya Hashimoto; Shozo Hojo; Isaku Yoshioka; Tomoyuki Okumura; Takuya Nagata; Tsutomu Fujii
Journal:  Surg Today       Date:  2019-11-11       Impact factor: 2.549

2.  Clinical effects of prophylactic transverse colostomy in patients undergoing completely laparoscopic transabdominal approach partial intersphincteric resection.

Authors:  Honghong Zheng; Zhehong Li; Rui Su; Jianjun Li; Shuai Zheng; Ji Yang; Enhong Zhao
Journal:  J Int Med Res       Date:  2022-04       Impact factor: 1.573

3.  Development and Validation of a Logic Model for Utilization of Nutrition Support among Patients with Cancer.

Authors:  Ngou In Pang; Ruixue Bie; Carolina Oi Lam Ung; Hao Hu
Journal:  Biomed Res Int       Date:  2020-06-24       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.